Supervised Walking Programs for Peripheral Vascular Disease: Why They Are Part of Treatment

She had a system for the supermarket. Bread aisle, pause. Dairy, pause. Read the back of a yogurt she had no intention of buying while the cramp in her right calf drained away. Nobody noticed, which was the point. By the time a clinician asked how far she could walk before her leg forced her to stop, she had spent two years quietly redrawing the map of her town so that no journey crossed that invisible line.

Then came the surprise. The treatment she was offered first was not a tablet or a procedure. It was a referral to a supervised walking program for peripheral artery disease: three appointments a week in a rehabilitation gym, walking on a treadmill until the ache arrived, resting, and walking again.

To someone whose legs already hurt when they walk, that can sound like being told the fix for a headache is more noise. This article explains why the evidence points the other way, what those sessions actually involve, and how they sit alongside everything else in the plan.

What is peripheral artery disease, and why do my legs hurt only when I walk?

Peripheral artery disease, usually shortened to PAD, is a narrowing of the arteries outside the heart and brain, most often in the legs, caused by atherosclerosis: the slow build-up of fatty, calcified plaque inside artery walls. At rest, a narrowed artery may still deliver enough blood to keep the muscle comfortable. Walking changes the math. Calf muscles working at pace or uphill need many times more oxygen than they do sitting down, and a narrowed pipe cannot keep up. The muscle switches to less efficient fuel pathways, acid accumulates, and the result is a cramping ache, heaviness or fatigue that appears after a predictable distance and fades within minutes of standing still. That pattern has a name: intermittent claudication, from a Latin word for limping.

Where the ache lands hints at where the narrowing sits. Calf pain usually points to disease in the thigh artery; buttock or hip pain suggests a blockage higher up, in the pelvis. Plenty of people with PAD never feel classic claudication. They notice they have become slower, or that their legs tire, and they quietly shorten their errands. Clinicians take this seriously for two reasons. The leg itself is at risk of poor healing and, in advanced disease, tissue loss. Just as important, plaque in a leg artery rarely travels alone; the same process is usually underway in the arteries of the heart and neck, which is why PAD is treated as a marker of overall cardiovascular risk (MedlinePlus).

Diagnosis is often confirmed with an ankle-brachial index, a painless comparison of blood pressure at the ankle with pressure at the arm. A ratio between 1.0 and 1.4 is considered normal, while 0.90 or lower supports a PAD diagnosis (Cleveland Clinic). That single number, combined with your walking history, is what usually opens the conversation about a structured walking program.

How does a walking program for peripheral artery disease actually work?

The intuitive theory is that walking forces the body to grow new detours around the blockage. Those small side routes, called collateral vessels, do enlarge in some people, and imaging studies confirm it. Collateral growth alone, however, does not explain the size of the improvement seen in trials, and it is probably not even the main driver.

A fuller picture runs through the muscle itself. Repeated bouts of walking to the point of discomfort, followed by recovery, train the calf to use oxygen more efficiently. Mitochondria, the tiny structures inside muscle cells that convert fuel into energy, increase in number and performance. Muscle fibres shift toward types that resist fatigue. The inner lining of the arteries, called the endothelium, becomes more responsive and releases more nitric oxide, a natural signal that relaxes vessel walls and improves flow. Chronic low-grade inflammation, which stiffens arteries, tends to ease. Walking economy improves as well: people settle into a stride and cadence that wastes less energy per step, which by itself can stretch pain-free distance.

None of these changes require the blockage to shrink, and it usually does not. That surprises people and explains a common frustration: a follow-up scan may look identical while your walking has doubled. The measure that matters here is function, not anatomy.

Amount matters as much as mechanism. Major cardiovascular organizations describe a specific prescription: sessions of about 30 to 45 minutes of intermittent walking, at least three times a week, continued for a minimum of 12 weeks (American Heart Association; Cleveland Clinic). The NHS frames a similar target as roughly two hours of exercise a week for three months. Below that threshold the training signal is too weak to remodel muscle and vessels. This is why the program is written like a prescription, with frequency and duration, rather than offered as a friendly nudge.

What actually happens at a supervised exercise session?

Most supervised programs run in a cardiac or vascular rehabilitation gym. The first visit is largely assessment. An exercise physiologist or physical therapist checks blood pressure and heart rate, reviews your medicines and other conditions, and measures your baseline on a treadmill: how far you walk before the first ache appears, and how far before you must stop. Those two distances become your yardsticks for the months ahead.

A typical session then follows a rhythm that feels strange at first. You walk on a treadmill at a speed and slight incline chosen to bring on claudication within a few minutes. When the discomfort reaches a moderate level, roughly a three on a four-point scale where four is the worst imaginable, you stop and stand or sit until it fully eases. Then you begin again. The cycle repeats until total walking time reaches the session goal, usually building from around 30 minutes toward 45 or more across the program (Cleveland Clinic). Rest periods count as part of the training; they are not cheating.

Staff adjust the treadmill as you improve. If you can now walk eight minutes before the ache instead of three, the speed or grade rises so the stimulus stays strong. Sessions include a brief warm-up and cool-down, and many programs add leg resistance work or arm cycling, both of which have supporting evidence when treadmill walking is limited by other problems such as arthritis.

Monitoring is the part a solo walk cannot replicate. Heart rate and blood pressure are checked, and if you have coronary disease alongside PAD, staff watch for chest symptoms or unusual breathlessness. Someone is also there to answer the question that stops many people in their tracks: is this pain the normal kind or the kind I should worry about? Being able to ask that in real time, week after week, is one reason people tend to stick with supervised programs longer than with advice alone.

Why is supervised exercise therapy for PAD considered treatment rather than advice?

For decades the standard guidance for claudication was a sentence at the end of the consultation: try to walk more. Results were poor, not because walking fails but because vague advice rarely becomes a training program. Randomized trials comparing structured, supervised walking with no exercise or general advice found consistent gains in both pain-free and maximal walking distance in the supervised groups. That body of evidence is why major cardiovascular guidelines list supervised exercise therapy as a first-line treatment for symptomatic PAD, on the same tier as medicines that protect the heart and ahead of procedures for most people whose only problem is claudication (American Heart Association; Mayo Clinic).

First-line carries weight. It means clinicians are expected to offer it before considering a stent or bypass for claudication alone, and it means the program should be prescribed with structure: how often, how long, how hard. In the United States, public insurers recognize supervised exercise therapy as a covered medical treatment with a defined format, which shows how firmly it sits in mainstream care.

The comparison with procedures is instructive. Angioplasty, in which a small balloon opens the narrowed artery, often produces a quicker jump in walking distance during the first months. Trials that followed people for a year or more generally found that supervised exercise caught up in functional terms, and that combining the two produced better results than either alone. Exercise also delivers benefits a stent cannot: lower blood pressure, better blood sugar handling, healthier cholesterol profiles and improved mood.

Framing walking as treatment also changes the conversation about disappointing results. If someone has not improved after 12 weeks, the right response is not a lecture on effort but the same approach used for any therapy: confirm the prescription was followed, look for barriers, and revisit the plan with the vascular team. Treatment can be adjusted. It is never a verdict on character.

Supervised program, home exercise program for PAD, or simply walking more: how do they compare?

Not everyone lives within reach of a rehabilitation gym, can attend three times a week, or wants to. Researchers have therefore tested structured home-based programs, and the results matter for how you plan with your team. The key finding is that structure, not location, does most of the work. A home program that includes a written prescription, a log book or step counter, and regular check-ins by phone or in clinic performs far better than unstructured advice, and in several trials approached the gains of supervised sessions (American Heart Association).

Approach	What it looks like	What the evidence shows	Usually suits
Supervised exercise therapy	Treadmill sessions in a rehab setting, 30–45 minutes, three or more times weekly for at least 12 weeks, with staff monitoring	Strongest and most consistent improvement in walking distance; recommended first-line in guidelines	Most people with claudication, especially those with heart disease or low confidence
Structured home-based program	Written walking plan, activity monitor or diary, scheduled coaching contact, periodic reassessment	Clear benefit over advice alone; can approach supervised results when adherence is high	People far from a center, with transport limits, or continuing after a supervised block
General advice to walk more	Encouragement without a defined frequency, duration or intensity	Little measurable change in most studies	Not an adequate substitute for either program

The table hides one practical truth: the two structured options are not rivals. A common sequence is a supervised block first, where you learn the stop-start technique with someone watching your heart and blood pressure, followed by a home program to protect the gains. Some teams reverse the order when a place in a supervised program is not immediately available, so that no months are lost. Which sequence fits you depends on your heart history, mobility and circumstances, and that judgment belongs to your vascular team.

Who is a supervised walking program usually for, and who is asked to wait?

The clearest candidate is someone with confirmed PAD whose main symptom is claudication: leg pain, cramping or heaviness brought on by walking and relieved by rest. Guidelines recommend supervised exercise for this group regardless of age, and trials have included people well into their eighties (American Heart Association). Programs are also offered to people with a low ankle-brachial index who report no classic pain but have noticed their walking speed or distance slipping, since function tends to decline without treatment.

Several situations lead a team to pause or choose a different route first. The most important is chronic limb-threatening ischemia, an advanced form of PAD in which blood flow is so reduced that pain occurs at rest, often at night in the foot, or a sore fails to heal. Exercise is not the first step here; these people need urgent assessment for a procedure to restore flow, because the priority is protecting the limb (Mayo Clinic). An open ulcer or infection on the foot also puts treadmill walking on hold until it has healed.

Heart conditions shape the timing too. Unstable angina, a recent heart attack, an uncontrolled heart rhythm problem, severe narrowing of the aortic valve or very high resting blood pressure are typically stabilized before an exercise prescription begins, and the assessment may include a cardiac stress test. This is a delay, not a refusal.

Other limits are practical rather than dangerous. Severe knee or hip arthritis, balance problems, foot deformity or a prior amputation can make treadmill walking unsafe or impossible. Programs then substitute arm cycling or seated resistance training, which also improve walking capacity in studies. The message is that almost everyone with PAD can be offered some structured exercise; the form and the start date are decisions for the treating team.

What do the first weeks of a walking program for peripheral artery disease look like?

Week one is mostly humbling. The baseline treadmill test tells you, in metres or minutes, a number you may have been avoiding. Then come the first sessions, and the ache arrives right on schedule. Many people report a specific kind of doubt at this stage: the discomfort feels like proof that walking is wrong for them, and the stop-start rhythm feels like failing repeatedly in public. Staff expect this and will say so. Mild muscle soreness the next day is common and is a sign of training, not injury.

Somewhere in the second to fourth week, most people notice the first shift. It rarely feels dramatic. The cramp turns up a little later, or eases a little sooner during the rest break, or the treadmill grade has quietly crept up without the session feeling harder. Keeping a simple log of onset time and total walking time makes these small changes visible, which matters for motivation.

The middle weeks are where the physiology described earlier does its work. Speed and incline keep rising to match your capacity, total walking time per session heads toward the upper end of the 30 to 45 minute range, and everyday tasks start to change before treadmill numbers do: the far parking space, the extra flight of stairs, the shopping trip completed without the yogurt-label pause.

Programs are typically designed around a minimum of 12 weeks, or roughly three months, because that is the duration studied in the trials underpinning guideline recommendations (American Heart Association; NHS). At the end, a repeat treadmill test compares onset and maximal distance against your baseline. What follows matters as much as what came before: gains fade when walking stops, so the program should end with a maintenance plan, usually a structured home schedule with periodic reviews. Improvement is common but not universal, and the pace differs from person to person; your team will interpret your own numbers rather than an average.

Is walking with claudication pain safe, or am I damaging something?

This is the question underneath almost every hesitation, and the answer for claudication is reassuring. The pain is a signal of temporary oxygen shortage in working muscle, much like the burn a healthy runner feels near the end of a sprint. It is reversible. When you stop, flow catches up with demand within minutes, acid clears and the tissue returns to normal. Decades of trials in which people deliberately walked into moderate claudication several times a week have not shown muscle damage or worsening of the artery disease; the opposite pattern, improved function, is what the data show (Cleveland Clinic; American Heart Association).

Technique makes the difference between productive discomfort and misery. The target is moderate pain, not the maximum you can tolerate. Walking until you are hobbling does not add benefit and makes the next session feel like a threat. Stopping at the first twinge, on the other hand, undercuts the training stimulus. The middle ground, roughly a three on that four-point scale, is where programs aim, and rest should last until the ache has fully gone rather than merely faded.

Two kinds of pain are different in nature and should not be walked through. The first is pain in the foot or toes that appears at rest, particularly at night and relieved by hanging the leg over the bed; this points to severely restricted flow and needs prompt review. The second is anything that suggests the heart rather than the leg: chest pressure, pain spreading to the jaw or arm, sudden breathlessness, light-headedness or a racing, irregular heartbeat. Those are reasons to stop immediately and seek care, not to rest and resume.

Skin is the other consideration. Reduced blood flow slows healing, so blisters or pressure sores from ill-fitting shoes are not trivial. A daily foot check, described later, keeps a small problem from becoming a reason to pause the program.

How does walking fit alongside medicines, angioplasty and bypass surgery?

Walking treats the symptom and improves function. Medicines mostly address the risk that PAD signals: heart attack and stroke. Nearly everyone with PAD is considered for an antiplatelet medicine, a class that makes blood platelets less likely to clump and form clots on rough plaque, and for a statin, a class that lowers LDL cholesterol and appears to stabilize plaque so it is less likely to rupture (Mayo Clinic; NHS). Blood pressure and blood sugar medicines join the plan when needed. None of these are optional extras to the walking program; the two halves address different dangers.

One medicine class targets walking distance directly. Cilostazol, a generic medicine that widens blood vessels and reduces platelet stickiness, has been shown in trials to modestly extend pain-free walking, and guidelines list it as an option for claudication in selected people (Mayo Clinic). It is not suitable for everyone, particularly people with heart failure, and it is judged over a period of weeks rather than days. Whether it belongs in your plan, and for how long, is a decision for your prescribing clinician; it is used alongside exercise, not instead of it.

Procedures come into view when claudication still limits daily life despite a completed exercise program and optimized medicines, or immediately when blood flow is low enough to threaten the limb. Angioplasty uses a balloon, often with a stent, a small mesh tube that holds the artery open, to widen the narrowing from the inside. Bypass surgery reroutes blood around a long blockage using a vein or synthetic graft. Both carry risks, including bleeding, infection, re-narrowing and, for surgery, the general risks of anesthesia, and neither halts the underlying disease.

Here is the point people miss: exercise does not end when a stent goes in. Trials combining a procedure with supervised walking generally outperform either alone, and the risk-factor benefits of walking continue regardless of what was done to the artery.

What people often get wrong about walking and peripheral artery disease

The most damaging misunderstanding is that rest is the safer choice. It feels logical: the leg hurts when you walk, so walk less. In practice, inactivity accelerates the loss of muscle and fitness, worsens blood pressure and blood sugar, and shrinks the world a little more each month. The evidence points firmly toward structured walking as the protective option for claudication (American Heart Association).

A second myth is that the pain means the muscle is being harmed. As described above, claudication is a reversible oxygen shortage. It is a training signal, not a warning of injury, provided you stop at moderate discomfort and rest fully.

The third is the mirror image: that walking will dissolve the plaque or open the artery. It will not, and expecting it to sets people up to feel cheated at a follow-up scan. The blockage typically looks the same. What changes is how efficiently the muscle downstream uses the blood it gets, and how far you can walk as a result.

People also assume any exercise counts equally. Cycling and swimming are excellent for the heart and are good options when walking is impossible, but treadmill walking that provokes claudication has the strongest evidence for extending walking distance specifically, because it trains the exact muscles and the exact deficit involved.

Then there is age. Trials have enrolled people in their eighties, and improvements are not confined to the young. Programs adjust speed and incline to the individual; the principle is the same at any age.

Finally, some believe a stent or bypass means the walking can stop. Procedures restore flow in one segment of one artery. They do nothing for the plaque elsewhere, and re-narrowing is a real risk. Walking, medicines and smoking cessation remain the long-term treatment whether or not a procedure has been done.

Shoes, feet and skin: the small details that keep you walking

Reduced blood flow to the legs means small injuries heal slowly, and if diabetes is also present, nerve damage may mean you do not feel a blister forming. A walking program that ends because of a preventable foot sore is a needless loss, so programs spend real time on feet.

Footwear comes first. Shoes should be walking or athletic shoes with a firm heel, a cushioned sole and enough room across the toes that nothing rubs. Shopping later in the day, when feet are slightly swollen, gives a truer fit. Seams inside the shoe that you can feel with a finger will eventually leave a mark on skin. Socks should be smooth, moisture-wicking and free of tight elastic bands that ridge the skin.

A daily foot check takes under a minute. Look at the soles, between the toes and around the heels for redness, blisters, cracks, colour change or any break in the skin; a hand mirror helps if bending is difficult. Wash and dry thoroughly, especially between the toes, and moisturize dry skin but not the gaps between toes where dampness invites fungal infection. Nails are trimmed straight across. Anyone with diabetes or numb feet is generally advised to have corns, calluses and thickened nails managed by a podiatrist rather than at home (NHS).

Report rather than wait. A sore that has not begun to heal within a few days, or any wound that is warm, swollen, discharging or spreading redness, needs a clinician to look at it promptly. Your rehabilitation staff would rather you flag a red patch than hide it to avoid missing a session; they can switch you to arm cycling while the skin recovers.

Surfaces matter for the home program. Flat, well-lit routes with places to rest, indoor malls in bad weather, and a phone in your pocket turn a good intention into a repeatable habit.

Smoking, blood sugar and blood pressure: why the walking plan does not stand alone

Plaque in a leg artery is a local symptom of a body-wide process, and the walking program treats the leg. The rest of the plan addresses the process, and one part of it outweighs everything else. Tobacco smoke damages the artery lining, promotes clotting and drives plaque growth faster than any other modifiable factor in PAD; people who continue to smoke have higher rates of disease progression, amputation and failed procedures, and quitting is described by every major guideline as the single most effective step a person with PAD can take (Mayo Clinic; American Heart Association). Nicotine replacement products and prescription medicines can double or triple quit rates compared with willpower alone, and asking your team for referral to a cessation program is a legitimate part of vascular treatment, not a side issue.

Diabetes is the second accelerant. High blood sugar over years stiffens and narrows small and large vessels and damages the nerves that would otherwise warn of a foot injury. Good glucose control slows this, and exercise itself improves how muscle takes up sugar, which is one reason walking and diabetes care reinforce each other.

High blood pressure and raised LDL cholesterol round out the list. Both are usually managed with a combination of diet, activity and medicines chosen by your clinician, with targets that are stricter for people with established artery disease than for the general population. A largely plant-forward diet with less processed meat, fewer refined carbohydrates and limited salt supports all three goals.

The practical upshot is that a walking program works best as one gear in a machine. Some people find the program becomes the anchor for the rest: the routine of showing up three times a week makes it easier to keep the smoking quit going and the medicines taken. Others find the opposite order works. What matters is that the whole plan is reviewed together, by the team that knows your history.

Questions to ask your care team before and during a walking program

Good programs welcome questions, and a short list written in advance keeps the consultation focused on what matters to you. These are the ones patients most often wish they had asked earlier.

• What did my ankle-brachial index and any imaging show, and does that pattern affect what kind of exercise you recommend?
• Am I a candidate for supervised exercise therapy, and if a place is not available soon, can I start a structured home program in the meantime?
• Do I need a heart assessment or stress test before I begin, given my history?
• How will I know the difference between claudication I should walk through and pain that means I should stop?
• What are my baseline walking distances, and how will we measure change at the end of the program?
• Which of my medicines are for symptoms and which are for protecting my heart and brain, and how long before each is expected to show an effect?
• If I do not improve after the program, what are the next options, and what are their risks?
• How should I care for my feet during training, and who do I contact if I find a sore?
• Can you refer me for help stopping smoking, and does that change my results?
• What does the maintenance plan look like once the supervised sessions end?

Bring a log of how far you can walk now and what stops you; it is the single most useful piece of information you can offer. If you have arthritis, balance concerns, a previous amputation or a heart condition, say so at the first visit rather than waiting to see whether the treadmill copes. Programs adapt readily, but only to what they know.

None of these questions has a universal answer. The point of asking is to leave with a plan that is yours, agreed with the people who will follow you through it.

When to call your doctor

Claudication that eases with a few minutes of rest is expected during a walking program. Several other symptoms are not, and they should prompt a call the same day or emergency care, depending on severity.

Seek emergency care immediately if a leg or foot becomes suddenly cold, pale or bluish, numb, weak or impossible to move, or if severe leg pain comes on abruptly and does not ease with rest. This can indicate acute limb ischemia, a sudden blockage that threatens the limb within hours (Johns Hopkins Medicine). The same urgency applies to chest pain or pressure, pain spreading to the arm, neck or jaw, sudden breathlessness, fainting, or a face that droops or speech that slurs, all of which may signal a heart attack or stroke.

Contact your doctor promptly, within a day, if you develop pain in the foot or toes at rest, particularly at night; a sore, blister or cut on the foot that has not begun to heal within a few days; skin that is red, warm, swollen or draining; a toe or area of skin that turns dark or black; or claudication that is suddenly much worse than your usual pattern at a given distance. New calf swelling with tenderness, especially in one leg, needs same-day review to rule out a clot in a vein.

Also let the team know about dizziness, palpitations or unusual breathlessness during sessions, or any new medicine started by another clinician, since interactions can affect blood pressure and exercise safety.

The walking program treats a chronic condition, and chronic conditions change. Reporting early lets your team adjust the plan, whether that means a short pause, a switch to arm exercise while skin heals, or a fast referral for imaging. Every one of those decisions rests with the clinicians who know your case.

Frequently asked questions

How far should I walk with PAD?

Programs use time rather than distance: you walk until claudication reaches a moderate level, rest until it fully clears, and repeat until you have accumulated about 30 to 45 minutes of walking in a session, according to the American Heart Association and Cleveland Clinic. Distance rises naturally as the weeks pass. A treadmill test at the start gives you a personal baseline, and your team adjusts speed and incline to keep the effort moderate rather than exhausting.

Is a home exercise program for PAD as effective as a supervised one?

Supervised programs have the strongest evidence and are recommended first-line, but structured home programs that include a written prescription, a step counter or diary and regular coaching contact deliver clear benefit and, in some trials, approached supervised results. Unstructured advice to walk more performs poorly. Many teams combine the two, starting supervised and continuing at home, and the right sequence depends on your heart history and circumstances.

Does walking with claudication pain damage my legs?

No. Claudication is temporary oxygen shortage in muscle that resolves within minutes of rest, and decades of trials in which people walked into moderate discomfort several times a week found improved function rather than harm. What should not be walked through is pain in the foot at rest, an open sore, or any chest pain, breathlessness or dizziness, which need prompt medical attention.

How long before a walking program for peripheral artery disease shows results?

Programs are designed around a minimum of 12 weeks, or about three months, because that is the duration studied in the trials behind guideline recommendations, according to the AHA and NHS. Many people notice the cramp arriving a little later within the first few weeks, but the pace varies widely and some improve slowly or modestly. Your team compares your own repeat treadmill test against your baseline rather than an average.

Can I join supervised exercise therapy for PAD if I have arthritis or poor balance?

Usually yes, in an adapted form. Treadmill walking may be replaced or supplemented with arm cycling, seated resistance training or walking with handrail support, all of which have shown improvements in walking capacity in studies. Tell the program about joint pain, balance problems or previous falls at the first assessment so staff can design a safe plan; the choice of format is theirs to make with you.

Should I still do a walking program after a stent or bypass?

Guidelines recommend continuing structured exercise after a procedure. Angioplasty or bypass restores flow in one segment of one artery but does not stop plaque elsewhere or prevent re-narrowing, and trials combining a procedure with supervised walking generally outperform either alone. Your vascular team will advise when to start after the procedure and whether any restrictions apply to the wound or access site.

Is cycling or swimming just as good as walking for claudication?

Both are good for the heart and useful when walking is limited, but treadmill walking that provokes claudication has the strongest evidence for extending walking distance specifically, because it trains the exact muscles and the exact deficit involved. Some programs add cycling or resistance work alongside walking. If walking is impossible for you, structured alternative exercise is far better than none, and your team can help choose.

Why does my scan look the same even though I can walk much further?

Because the walking program works mainly downstream of the blockage. Mitochondria in the calf muscle increase, the artery lining releases more nitric oxide, fibres become fatigue-resistant and stride efficiency improves, while the plaque itself typically does not shrink. Clinicians judge the treatment by function, using walking distance and time, rather than by the appearance of the narrowing on imaging.

Will the gains last if I stop walking after the program ends?

They tend to fade. Muscle and vessel adaptations are maintained by continued training, so programs should finish with a maintenance plan, usually a structured home walking schedule with periodic reviews. Most people need at least the two hours a week described by the NHS to hold their gains. If circumstances force a break, tell your team so the plan can be adjusted rather than abandoned.

Does a supervised walking program lower my risk of heart attack or stroke?

Regular exercise improves blood pressure, cholesterol, blood sugar and inflammation, all of which drive heart attack and stroke risk, and PAD is treated as a marker of that risk. Direct trial proof that supervised exercise therapy alone reduces cardiovascular events is limited, so the walking program is combined with antiplatelet and statin medicines, smoking cessation and risk-factor control, which have stronger evidence for preventing those events.

References

• MedlinePlus: Peripheral Arterial Disease
• NHS: Peripheral arterial disease (PAD), Treatment
• Cleveland Clinic: Peripheral Artery Disease (PAD)

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.